Aurobindo gets approval for Abacavir Sulfate/Lamivudine tab

16108 Investors following Aurobindo Pharm. Share this News with them.

0

Like this story, share it with millions of investors on M3

Aurobindo gets approval for Abacavir Sulfate/Lamivudine tab

Aurobindo Pharma Limited is pleased to announce that it has received the tentative approval to manufacture and market Abacavir Sulfate / Lamivudine tablets 600mg/300mg from the US Food & Drug Administration

Post your opinion here

 

0

Tweet

Share on Tumblr

RELATED NEWS Aurobindo gets approval for cefazolin for injection USP Aurobindo Pharma gets approval for Alendronate Sodium Tabs Aurobindo Pharma Q1 net profit at Rs 16.4 cr ALSO READ See latest News about Aurobindo Pharm See previous management interviews See what other Experts & Brokerages are saying about Aurobindo Pharm Aurobindo Pharm BSE | NSE 25/05/12 Are Mutual Funds betting on Aurobindo Pharm?

Aurobindo Pharma Limited is pleased to announce that it has received the tentative approval to manufacture and market Abacavir Sulfate / Lamivudine tablets 600mg/300mg from the US Food & Drug Administration (USFDA).

Abacavir Sulfate / Lamivudine tablets 600mg/300mg are the generic equivalent of Epzicom® tablets 600mg/300mg of SmithKline Beecham Corporation and falls under the anti-retroviral (ARV) segment. This product has been reviewed under the President's Emergency Plan for AIDS Relief (PEPFAR)

This is Aurobindo's 76th ANDA approval from USFDA. 

Sourced From: Aurobindo Pharma Limited